This is like coding new instructions into the cell. The old instructions for the abnormal hemoglobin S (HbS) are still there, but now the cell can make normal HbA (hemoglobin A) and HbS. The vector ...
SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.
HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.
Clinical trials have shown that vildagliptin is effective in significantly lowering glycosylated hemoglobin (HbA 1c), fasting plasma glucose, and prandial glucose levels. Beta-cell function may ...
despite smaller reductions in hemoglobin (HbA 1c), according to systematic review and network meta-analysis study findings published in the Journal of the American Medical Association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results